Developing Medical Breakthroughs for Both Humans and Animals: Regulation Need-to-Knows
Date & Time
Tuesday, June 15, 2021, 12:00 PM - 12:30 PM
Linda Rhodes Bill Zollers

The road to an NADA compared to an NDA is shorter, and less costly, but still very challenging and difficult. There are many ways in which the regulatory path in animal health is less risky than in human health, not least because of the ability to do pilot studies in the client-owned animal population. In fact, almost no pivotal clinical studies fail for lack of effectiveness because pilot studies can be done prior to launching the pivotal study. This roundtable will address how to navigate the registration process in animal health, and share tricks of the trade that you need to know to get your product to market quickly.

Session Type
Virtual Session Link